Explore the words cloud of the NPX-101 project. It provides you a very rough idea of what is the project "NPX-101" about.
The following table provides information about the project.
Coordinator |
NEUROPREX EUROPE INC LTD
Organization address contact info |
Coordinator Country | United Kingdom [UK] |
Project website | http://www.neuroprex.webs.com |
Total cost | 71˙429 € |
EC max contribution | 50˙000 € (70%) |
Programme |
1. H2020-EU.3.1.4. (Active ageing and self-management of health) 2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)) 3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 4. H2020-EU.3.1.6. (Health care provision and integrated care) |
Code Call | H2020-SMEINST-1-2016-2017 |
Funding Scheme | SME-1 |
Starting year | 2016 |
Duration (year-month-day) | from 2016-06-01 to 2016-09-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | NEUROPREX EUROPE INC LTD | UK (LONDON) | coordinator | 50˙000.00 |
2 | OMSBAR LIMITED | UK (OXFORDSHIRE) | participant | 0.00 |
Over 450 million individuals face depression, with over 800,000 suicide deaths per year, delivering a death rate of one person every 40 seconds. These figures are set to increase as estimates put 1 out of 4 individuals in the future to face similar mental disorders at some stage of life. NPX-101 is the first product line for treating moderate to severe depression, especially the 30% of patients who are currently drug-resistant. It is a patented non-invasive bioelectronic device that delivers Transcranial Magnetic Stimulation (TMS) in the form of a wearable Magnetic Resonance Imaging (MRI) helmet with shield protection. It delivers more precise and deeper energy stimulation, for fuller more effective therapy, removing the side-effects and other treament discomforts with current day treatment. Phase 1 of the SME instrument fits into the overall company plan of NeuroPrex and Omsbar to reach the market by contributing the financial resources needed to plan a fast sound wider deployment of the NPX-101. It would importantly help to deduce the quickest routes of distribution and market uptake for its entry-point of the U.K.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NPX-101" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "NPX-101" are provided by the European Opendata Portal: CORDIS opendata.
CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research
Read MoreSensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.
Read MoreAn innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.
Read More